Our purpose is to make every pregnancy around the world safer.
Comanche Biopharma has raised $75.0M in total funding. The most recent round was Series B. The last funding was announced in January 2024.
Comanche Biopharma's investors include New Enterprise Associates, Lilly Asia Ventures, F-Prime Capital, Atlas Venture, Google Ventures.
Comanche Biopharma is headquartered in Concord, United States.
Our purpose is to make every pregnancy around the world safer.
Comanche Biopharma is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Comanche Biopharma — Funding & Investors." VCBacked, January 17, 2024, https://www.vcbacked.co/company/comanche-biopharma. Accessed July 19, 2026.
VCBacked. (2024). Comanche Biopharma — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/comanche-biopharma
{{cite web |title=Comanche Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/comanche-biopharma |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated